Aerie Pharmaceuticals Stock Price - AERI

14.63
0.60 (4.28%)
Upgrade to Real-Time
Regular Market
14.63
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Aerie Pharmaceuticals Inc AERI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.60 4.28% 14.63 14.04 14.68 14.27 14.03 10:14:48
Bid Price Ask Price Spread Spread % News
14.61 14.65 0.04 0.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
799 86,969 $ 14.30 $ 1,244,051 967,253 10.80 - 38.39
Last Trade Time Type Quantity Stock Price Currency
10:14:48 2 $ 14.61 USD

Aerie Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 679.83M 46.47M 45.46M $ 69.89M $ - -4.39 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 11.00 2.20%

more financials information »

Aerie Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AERI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week16.0916.1013.3414.381,275,059-1.46-9.07%
1 Month14.1016.5313.3415.211,050,0680.533.76%
3 Months14.1816.5310.8014.221,023,7940.453.17%
6 Months19.2726.2610.8017.84967,773-4.64-24.08%
1 Year36.5938.3910.8020.171,031,259-21.96-60.02%
3 Years55.5074.7510.8035.75675,406-40.87-73.64%
5 Years11.2374.7510.8032.46660,6203.4030.28%

Aerie Pharmaceuticals Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America.


Your Recent History
NASDAQ
AERI
Aerie Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.